Akums launches first-of-its-kind Lasmiditan dispersible tablets for rapid migraine care EP News Bureau Mar 18, 2026 Akums Drugs & Pharmaceuticals has announced the launch of the world’s first Lasmiditan dispersible tablets, marking an…
Eli Lilly’s migraine treatment wins US FDA approval Reuters Oct 15, 2019 The drug has been approved to treat acute migraine with or without aura, a sensory phenomenon or visual disturbance, in adults